These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25793396)
1. Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia. van der Linden MH; Seslija L; Schneider P; Driessen EM; Castro PG; Stumpel DJ; van Roon E; de Boer J; Williams O; Pieters R; Stam RW PLoS One; 2015; 10(3):e0120326. PubMed ID: 25793396 [TBL] [Abstract][Full Text] [Related]
2. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia. Aoki Y; Watanabe T; Saito Y; Kuroki Y; Hijikata A; Takagi M; Tomizawa D; Eguchi M; Eguchi-Ishimae M; Kaneko A; Ono R; Sato K; Suzuki N; Fujiki S; Koh K; Ishii E; Shultz LD; Ohara O; Mizutani S; Ishikawa F Blood; 2015 Feb; 125(6):967-80. PubMed ID: 25538041 [TBL] [Abstract][Full Text] [Related]
3. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Stumpel DJ; Schneider P; van Roon EH; Boer JM; de Lorenzo P; Valsecchi MG; de Menezes RX; Pieters R; Stam RW Blood; 2009 Dec; 114(27):5490-8. PubMed ID: 19855078 [TBL] [Abstract][Full Text] [Related]
4. miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia. Malouf C; Antunes ETB; O'Dwyer M; Jakobczyk H; Sahm F; Landua SL; Anderson RA; Soufi A; Halsey C; Ottersbach K Blood; 2021 Nov; 138(21):2066-2092. PubMed ID: 34111240 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene. Dou L; Li J; Zheng D; Li Y; Gao X; Xu C; Gao L; Wang L; Yu L Mol Biol Rep; 2013 Dec; 40(12):6811-9. PubMed ID: 24057258 [TBL] [Abstract][Full Text] [Related]
6. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression. Dou L; Zheng D; Li J; Li Y; Gao L; Wang L; Yu L Oncogene; 2012 Jan; 31(4):507-17. PubMed ID: 21706045 [TBL] [Abstract][Full Text] [Related]
7. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT. Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504 [TBL] [Abstract][Full Text] [Related]
8. Rationale for targeting BCL6 in Hurtz C; Chan LN; Geng H; Ballabio E; Xiao G; Deb G; Khoury H; Chen CW; Armstrong SA; Chen J; Ernst P; Melnick A; Milne T; Müschen M Genes Dev; 2019 Sep; 33(17-18):1265-1279. PubMed ID: 31395741 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. Menendez P; Catalina P; Rodríguez R; Melen GJ; Bueno C; Arriero M; García-Sánchez F; Lassaletta A; García-Sanz R; García-Castro J J Exp Med; 2009 Dec; 206(13):3131-41. PubMed ID: 19995953 [TBL] [Abstract][Full Text] [Related]
10. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants. Driessen EM; van Roon EH; Spijkers-Hagelstein JA; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW Haematologica; 2013 Jun; 98(6):937-44. PubMed ID: 23403319 [TBL] [Abstract][Full Text] [Related]
11. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation. Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation. Orlovsky K; Kalinkovich A; Rozovskaia T; Shezen E; Itkin T; Alder H; Ozer HG; Carramusa L; Avigdor A; Volinia S; Buchberg A; Mazo A; Kollet O; Largman C; Croce CM; Nakamura T; Lapidot T; Canaani E Proc Natl Acad Sci U S A; 2011 May; 108(19):7956-61. PubMed ID: 21518888 [TBL] [Abstract][Full Text] [Related]
13. Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair. Castaño J; Herrero AB; Bursen A; González F; Marschalek R; Gutiérrez NC; Menendez P Oncotarget; 2016 May; 7(21):30440-52. PubMed ID: 27119507 [TBL] [Abstract][Full Text] [Related]
14. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Thomas M; Gessner A; Vornlocher HP; Hadwiger P; Greil J; Heidenreich O Blood; 2005 Nov; 106(10):3559-66. PubMed ID: 16046533 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Uckun FM; Herman-Hatten K; Crotty ML; Sensel MG; Sather HN; Tuel-Ahlgren L; Sarquis MB; Bostrom B; Nachman JB; Steinherz PG; Gaynon PS; Heerema N Blood; 1998 Aug; 92(3):810-21. PubMed ID: 9680349 [TBL] [Abstract][Full Text] [Related]
17. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement. Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858 [TBL] [Abstract][Full Text] [Related]
18. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Krivtsov AV; Feng Z; Lemieux ME; Faber J; Vempati S; Sinha AU; Xia X; Jesneck J; Bracken AP; Silverman LB; Kutok JL; Kung AL; Armstrong SA Cancer Cell; 2008 Nov; 14(5):355-68. PubMed ID: 18977325 [TBL] [Abstract][Full Text] [Related]
19. MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL. van der Linden MH; Willekes M; van Roon E; Seslija L; Schneider P; Pieters R; Stam RW Cell Cycle; 2014; 13(5):834-44. PubMed ID: 24736461 [TBL] [Abstract][Full Text] [Related]
20. Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia. Marques EA; Neves L; Fonseca TC; Lins MM; Pedrosa F; Lucena-Silva N J Pediatr Hematol Oncol; 2011 Aug; 33(6):470-4. PubMed ID: 21436736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]